Parent Perspectives on Nirsevimab for Their Newborn.
Hinderstein S, Aragona E, Loyal J. Parent Perspectives on Nirsevimab for Their Newborn. Pediatrics 2024, 154 PMID: 39587878, DOI: 10.1542/peds.2024-067532.Peer-Reviewed Original ResearchConceptsRespiratory syncytial virusRespiratory syncytial virus prophylaxisRSV disease severityMaternal RSV vaccineHealth Belief ModelHealthy newbornsRSV vaccineRSV infectionParents of newbornsNewborn unitSyncytial virusNirsevimabSide effectsNewbornsBelief ModelPediatric hospitalMonoclonal antibodiesDisease severityCOVID-19 vaccineProphylaxisVaccineIncreasing overall awarenessInfantsPediatrician's recommendationPositively influence decisionFactors Associated With Nirsevimab Uptake in Healthy Newborns.
Aragona E, Shabanova V, Loyal J. Factors Associated With Nirsevimab Uptake in Healthy Newborns. Hospital Pediatrics 2024 PMID: 39544017, DOI: 10.1542/hpeds.2024-007986.Peer-Reviewed Original ResearchEarly Experiences With Nirsevimab: Perspectives From Newborn Hospitalists.
Aragona E, Joshi N, Birnie K, Lysouvakon P, Basuray R. Early Experiences With Nirsevimab: Perspectives From Newborn Hospitalists. Hospital Pediatrics 2024, 14: e170-e172. PMID: 38115681, DOI: 10.1542/hpeds.2023-007639.Peer-Reviewed Original Research